Eurofins : S1 2020 légèrement au-dessus de nos attentes, les tests COVID-19 commencent à bien progresser en juillet. OC 640 € vs 600 €
>Légèrement au-dessus de nos attentes - Eurofins a publié ce matin ses résultats semestriels 2020, de bonne facture et un peu au-dessus de nos attentes. Le CA ressort à 2 323 M€, en progression de +7.2%, dont 5.1% en organique, et en accélération séquentielle (orga. T2 6.1% vs 4.1% au T1).L’EBITDA ajusté ressort à 493 M€ vs 480 M€e, soit une hausse de +210 pb (18.9%). Les SDI (Separately Disclosed Items) ressortent à 35 M€ vs 44 M€ en n-1 (et un niveau attendu en...Eurofins Scientific is an international life sciences company operating in food & pharmaceutical products testings. Co. provides analytical testing services to clients from various industries including pharmaceutical, food, and environmental sectors. Co. offers analytical methods for evaluating the authenticity, origin, safety, identity, composition, and purity of biological substances & products. Co. verifies authenticity of products analyzed to detect dangerous components (pathogens, prions, pesticides, asbestos, mycotoxins, dioxins, toxic substances, etc.). Co. operates in Benelux, France, Germany, North America, Scandinavia, British Isles (U.K. & Republic of Ireland), & other countries.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.